All funds

DNB Health Care B

Equity fund

1 year

Globe

USA

Largest region

Medium

Risk

Annual costs

Morningstar

 

Partial 

Sustainability

Development

Last 5 years
( ann.)

Details

  • DNB Health Care er et aktivt forvaltet aksjefond som hovedsakelig investerer i aksjer i selskaper innenfor helsetjenester, legemiddel, medisinsk utstyr, bioteknologi og annen beslektet virksomhet, notert på børser og regulerte markeder over hele verden. USA er en vesentlig del av helsemarkedet og fondet vil normalt ha en betydelig andel av investeringene her.
    Read more

Investment horizon

  • DNB Health Care B is a Equity fund. This mutual fund type is suitable for those who plan to save for at least 6 years.

Characteristics

  • Minimum amount
  • Sharpe 3 years
  • NAV/Price

    08 Dec 2025

  • Margin rate
  • Start date
    21 Sept 2023
  • ISIN
    NO0013004614

Risk

  • Medium (3 of 7)

Morningstar rating

  • The Morningstar Rating is an objective standard that tells us how well a fund has done compared to similar funds. If a fund performs better than other funds it is compared with, it receives a high rating. Correspondingly, a fund receives a low rating if it performs worse than similar funds.

Sustainability

Annual cost

  • Ongoing costs

    Includes management fees of 0,80 %

  • Platform fee
  • Kickback fee
  • Annual running costs

Other costs

  • Performance-based fee
  • Transaction costs

  • Costs for any currency exchanges are not included.

Allocation

  • Stocks 98%
    Interest 2%

Portfolio

Shows the fund's largest investments.

  • Eli Lilly and Co
    7.5%
  • AstraZeneca PLC
    6.1%
  • Johnson & Johnson
    6.0%
  • Roche Holding AG
    5.9%
  • UnitedHealth Group Inc
    4.6%
  • Novo Nordisk AS Class B
    4.5%
  • Sanofi SA
    3.6%
  • Thermo Fisher Scientific Inc
    3.4%
  • Lonza Group Ltd
    3.2%
  • DexCom Inc
    3.0%